Category //

7 Articles

Strategy

High-level methodologies for business operations, AI integration, and market positioning.

Your AI Roadmap Is Wrong: Planning for a Future You Cannot Predict

AI moves too fast for a committed roadmap. The Bet Portfolio — exploit, explore, insure — replaces a linear plan with bets you rebalance as the future arrives.

strategyRecently Published

Measuring AI's Actual ROI: The Attribution Trap That Fools Everyone

Most AI ROI is attribution theater. The Value Attribution Ladder shows why only the counterfactual rung honestly proves that the AI caused the result.

strategyRecently Published

Build, Buy, or Neither: Where Your AI Advantage Actually Lives

The build-vs-buy AI question is wrong: you needn't own a layer to benefit. The Advantage Map decides build, buy, or neither — by edge and by what is core.

strategyRecently Published

Capability Is Becoming Free. Judgment Is Becoming Everything.

AI capability is commoditizing fast. The durable advantage is judgment: where to apply it, what to refuse, how to earn trust, what to fund. The AI-native stack.

strategyRecently Published

The AI Business Case That Survives a CFO: Total Cost of Ownership, Not Build Cost

Most AI business cases model only build cost and fail within a year. The Three Cost Curves — build, run, switch — model and defend an AI investment to a CFO.

strategyRecently Published

Why Most Enterprise AI Pilots Never Reach Production — and the Four Gates That Change the Odds

Most enterprise AI pilots fail in the organization, not at the model. The Four Gates — Value, Data, Trust, Economics — decide which pilots reach production.

strategyRecently Published

The Pilot Trap: Why Your AI Never Leaves the Lab

Most AI gets stuck in perpetual piloting. The Production Gradient turns the leap to production into a path of stations with exit criteria, so pilots graduate.

Subscribe to Field Notes

Get our latest architectural patterns, capability judgments, and enterprise AI insights delivered directly to your inbox. No spam, only rigorous analysis.

Ready for intake...